Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer

Published:2019-01 Issue:1 Volume:13 Page:36-39
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Almagthali Alaa G.,Alkhaldi Eman H.,Alzahrani Afnan S.,Alghamdi Ameera K.,Alghamdi Waleed Y.,Kabel Ahmed M.

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference35 articles.

1. Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling;Kabel;Biomed Pharmacother,2018

2. Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1;Kabel;Physiol Behav,2018

3. Dipeptidyl Peptidase-4 (DPP-4) inhibitors in the management of diabetes;Pathak;Int. J. Pharm. Therapeut.,2010

4. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials;Monami;Nutr Metabol Cardiovasc Dis,2010

5. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme;Matteucci;Curr Med Chem,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials;Clinical Therapeutics;2024-08

2. Discovery of Nine Dipeptidyl Peptidase-4 Inhibitors from Coptis chinensis Using Virtual Screening, Bioactivity Evaluation, and Binding Studies;Molecules;2024-05-14

3. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28

4. Pharmacotherapy of type 2 diabetes: An update and future directions;Metabolism;2022-12

5. The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors;Thoracic Cancer;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3